Objective: to compare the clinical and laboratorial data before and after the treatment of patients with visceral leishmaniasis admitted to a pediatric hospital in a nonendemic area, highlighting the importance of recognizing visceral leishmaniasis in pediatric patients.
Introduction
Cutaneous and visceral leishmaniasis had already been diagnosed in man in ancient times. In India, visceral leishmaniasis (VL) was considered a highly fatal disease and was called Kala-azar (black fever) due to the dark appearance it caused on the skin.
The causing agent of VL in Americas is an obligatory intracellular parasite, family Trypnosomatidae, genus and subgenus Leishmania and species chagasi -L. (L.) chagasi. 1 The estimation for VL acquisition worldwide amounts to 182 million people, and is considered endemic in 47 countries. 2 In the American continent, Brazil has the highest endemic rate, reaching approximately 97% of all cases. The Brazilian northeastern region represents 90% of reported cases. The incidence rate in Brazil was 7.8 per 100,000 inhabitants in 1995. 3, 4 In Brazil, VL used to have a rural distribution until recently; however, after the 1980's, it spread into the periurban areas of big cities. 4 Experiments and human experimentation revealed immune response after infection by Leishmania, with a predominance of T helper type II lymphocytes (Th-2) and inadequate production of interleukin-2 (IL-2) and gammainterferon (gamma-INF) at the stationary phase of VL. The levels were restored after treatment. 5, 6 American VL affects children aged between one and four years old, and is regarded as a spectral disease whose clinical symptoms range from asymptomatic forms to classic symptoms, which include fever, anemia, hepatosplenomegaly, hemorrhage, in addition to lymphadenomegaly, weight loss, tachycardia and less frequently, dry cough and diarrhea. Signs and symptoms of malnutrition develop as the disease progresses, and include peripheral edema, hair loss and disorders of the skin and fingernails. 7, 8 The diagnosis of suspected VL must be based on epidemiological data and clinical and laboratory findings. However, the definite diagnosis can only be established by the detection of the parasite in the infected tissue.
Serological tests, such as IIF have good sensitivity, but may present cross-reactivity with antigens from other organisms such as Trypanosoma, Mycobacterium, Plasmodium and Schistosoma. 9 Antigen tests for leishmania by polymerase chain reaction (PCR) have high sensitivity and specificity, but they have to be carefully performed, especially in patients from endemic areas with high antigen exposure. 10, 11 Antimonial compounds, discovered at the beginning of the century, are still the treatment of choice for several kinds of leishmaniasis and are recommended by the World Health Organization. 12 The authors compare the clinical and laboratory date in the pre and post-treatment periods in patients with visceral leishmaniasis (VL) admitted to pediatric hospitals located in a nonendemic area, and show the importance of recognizing VL in this group of patients.
Patients and methods
Seventy-eight children enrolled at the Children's Institute, Department of Pediatrics, School of Medicine, Universidade de São Paulo (USP), participated in the study from January 1981 to July 1992. The data were obtained by the retrospective analysis of medical records until 1984 (29 children) and, later, 49 patients were prospectively studied.
All patients were referred for diagnostic analysis, since their liver and/or spleen presented abnormal size, with or without fever. Ten patients had already received treatment for VL, but did not show clinical improvement. All patients were submitted to a clinical protocol that included: identification, origin, major complaints, length of symptoms, existence of previous treatment for VL, and complete physical exam performed by the same examiner in the prospective group, ruling out other pathologies. The liver was palpated in the right midclavicular line (MCL), considering its size below the right costal margin (RCM), establishing the fifth right intercostal space in the HCL as upper limit. The size of the spleen was obtained by palpation of its largest axis below the left costal margin (LCM).
The following exams were carried out according to the described methods: automatic counter blood test (TOAMicrocell, Counter CC-108) and Leishman's smear; protein electrophoresis by biuret reaction and electrophoretic fractioning in cellulose acetate. Albumin levels greater than or equal to 3.5g/dl and gammaglobulin levels less than or equal to 1.6g/dl were considered normal; serological test by indirect immunofluorescence (IIF), using promastigote antigens from L.(L.) chagasi (titers > 32 were considered positive); serum levels of immunoglobulin classes and subclasses by radial immunodiffusion, using monoclonal antibodies for each IgG subclass from UNIPATH (UK), with WHO 67/97 reference standard, comparing with the values obtained for the subclasses of healthy Brazilian children; 13 myelogram done at the postero-superior iliac crest with Leishman's staining; bone marrow aspirate culture for the identification of Leishmania in biphasic medium (solid phase -NNN -Nicole, Novy, McNean 14 and liquid phase -BHI -brain-heart-infusion), kept for 10 days in heaters at proper temperature; liver biopsy performed with Tru-cut needle and submitted to hematoxylin and eosin staining and/or immunoperoxidase for Leishmania antigens; spleen puncture using the technique described by Ho et al., 15 with Leishman staining and quantification of amastigote forms carried out by the technique developed by Chulay et al.; 16 other exams were conducted according to the needs of each patient and as control of treatment and of the side effects from administered medication. The data analysis showed normal distribution (Kolmogorov-Smirnov test), and the paired t test was used, comparing the variable means before and after treatment. Albumin and gammaglobulin levels were compared by Fisher's test, taking into account normal levels before and after treatment. Leukocyte count less than 5,000 mm 3 , neutrophils less than 500/mm 3 and platelet count less than 100,000/mm 3 were also compared before and after treatment. The means for the length of the disease, hemoglobin, total leukocyte count, neutrophils, albumin, and length of hospital stay were compared among patients who developed or not secondary infection, using nonpaired t test. The level of significance for all statistical tests was 5% (P < 0.05).
Results
Most patients belonged to the state of Bahia (61 cases), while other cases belonged to Piauí(6), Minas Gerais(4), Pernambuco(3), Ceará(2), Mato Grosso and Goiás (one case each).
The mean age was 4 years and 10 months (median of 4 years and one month) with a variation between 8 months and 13.5 years. Sex distribution showed a slight predominance of males (1.29 males/1 female).
The assessment of anthropometric measures at the time of inclusion revealed percentiles < 10% for weight and height in 66% and 77.4% of patients, respectively.
The initial complaints reported by family members and the major clinical symptoms at diagnosis are shown in Table 1 . The mean length of complaints was 5.6 months. Splenomegaly, hepatomegaly, anemia and fever were the most frequent symptoms.
All patients were submitted to different diagnostic methods for identification of the parasite, and in 74 patients (94.5%), the results were positive ( Table 2 ). The positive result of the myelogram and bone marrow culture were respectively 77% and 66.6%. In seven cases, bone marrow culture was the only method that revealed the existence of leishmania, where repeated myelograms were not able to detect the parasite. The identification of the parasite was possible in 67 cases (85.7%), by combining myelogram and bone marrow culture. In cases in which the parasite could not be initially diagnosed (11 patients), liver biopsy was conducted in five patients and spleen puncture was done in two cases. These methods allowed for the identification of the parasite. The presence of the parasite could not be confirmed in four patients due to clinical or laboratory contraindication of bone marrow aspiration and puncture, since bleeding, thrombocytopenia and/or coagulogram abnormal results were present. In these cases, the analysis of epidemiological, clinical and laboratory data was enough to implement treatment, followed by clinical and laboratory response.
The mean hemoglobin levels, the total leukocyte count, neutrophil count, platelet count, serum levels of albumin and gammaglobulin of 78 patients before and after treatment are shown in Table 3 . The hemoglobulin level before treatment ranged from 3.3 to 11.1g/dl and from 4.8 to 13.1g/dl after treatment. Erythrocyte transfusion was necessary in 19 patients before or during the treatment. The total leukocyte count was recorded in 78 patients before the treatment, showing less than 5,000/mm 3 in 67 cases (85.9%). The total neutrophil count before the treatment was less than 500 /mm 3 in 14/78 cases (18%) and in 4/67 patients (6%) after the treatment (P< 0.001). The platelet count before the treatment was less than or equal to 100,000/mm 3 in 47 / 71 cases (66.2%) and in 4/65 (6.1%) after the treatment, showing statistically significant difference (P < 0.001).
The serum levels of albumin and gammaglobulin were measured in respectively 77 and 74 patients before the treatment and in 38 patients after the treatment. There was statistically significant difference between the mean values for albumin before and after treatment. The level of gammaglobulin before the treatment ranged from 0.91 g/dl to 8.89 g/dl and between 0.90 g/dl and 6.42 g/dl after the treatment, without any statistically significant difference between the mean values (P=0.087). The normal serum levels of albumin and gammaglobulin were compared before and after treatment and are shown in Tables 4 and 5 .
The serological test by IIF was positive in 40/41 patients. The serum levels of immunoglobulin classes and IgG subclasses before and after treatment were high (> 97.5 percentile) for IgG and IgM in respectively 18/18 and 13/ 18 cases, and these levels were not reduced in the immediate posttreatment period. The level of IgG1 was high (> 97.5 percentile) in all patients, either before (10/10 cases) or after treatment (16/16 cases). Low serum levels of IgG2 (< 2.5 percentile) were found in 2/10 cases before treatment and in 2/16 cases after treatment; the levels of IgG3 were considered low (<2.5 percentile) in 2/10 cases before treatment and in 1/16 cases after treatment. Fisher's test -P < 0.0001 Secondary infection occurred in 41 patients (52.5%), and 61 different infectious processes were detected. Bacterial pneumonia and skin infections (impetigo, erysipelas) and subcutaneous disorders (cellulitis) accounted for 59% of all infectious processes. Usual pediatric antibiotics were used, and no complications or death resulted from the infections. There was no significant difference between the duration of the disease, total leukocyte count, neutrophil count and initial albumin level with or without development of secondary infections. The comparison of the means for the length of hospital stay for patients who developed (35.7days) or did not develop (27.9 days) infection was not statistically significant (P=0.05).
The treatment of choice for VL was N-methyl glucamine (Glucantime ® ), and at the beginning (1981 through 1984) intravenous doses of 10mg/kg/day were administered every two hours in 25 patients. After that period, we used the doses recommended by the WHO (IV administration of 20mg/kg/day of Glucantime ® -daily, for at least 20 days) in 42 patients. Five patients received amphotericin B due to previous treatment with Glucantime ® or due to high level of transaminases. Patient VGS was diagnosed only by the immunoperoxidase technique for leishmania in liver tissue, showed spontaneous clinical improvement, was considered cured, and did not receive treatment. Five patients died due to bleeding associated or not with infection, before receiving any kind of treatment.
The mean length of hospital stay was 29 days in 72 patients who received some kind of treatment. There was remission of fever in 58/67 patients with a 10-day mean time for remission. Eleven patients did not have fever at any time during hospital stay, but eight of them had history of fever as initial complaint.
The progression of the mean size of liver and spleen is shown in Figure 1 , with remarkable, gradual reduction of measured values (P< 0.001) soon after treatment completion. The size of the liver was reduced in 27%, but the reduction of spleen size was more evident (38.9%).
Eleven patients (15.7%) did not show any symptoms after the first treatment scheme, but were considered cured after the second treatment scheme with Amphotericin B (10 cases) or new daily scheme with Glucantime ® (one case). 
Discussion
Leishmaniasis is considered a tropical or subtropical disease; however, it also assails Mediterranean countries or countries that receive travelers from endemic areas. 17, 18 In Brazil, only southern states do not have autochthonous cases. Many patients end up in general or tertiary hospitals in low-incidence areas and need to be properly diagnosed and treated. VL is a severe systemic protozoal infection that may cause death in untreated patients.
Most of our patients come from Bahia due to the easy access and available accommodation at the homes of relatives who live in São Paulo. Bahia is the Brazilian state with the highest number of reported cases, while Piauí is the state with the highest incidence of leishmaniasis in Brazil (28.9/ 100,000 inhabitants in 1994). 4 By analyzing the clinical status, we could observe the clinical variability of this disease, which was confirmed by the presence of patients with normal percentiles for weight (26 cases) and for height (17 cases). Malnutrition has been considered one of the major risk factors for VL; however, in the present study, we observed typical cases of VL with normal percentiles for weight and, especially, for height, showing that this diagnosis is possible even when chronic malnutrition is absent. On the other hand, extending the stationary phase of VL may affect the nutritional status of infected patients, with remarkable reduction of fat and muscle mass stores. 19 The duration of complaints among our patients was, on average, 5 months, a time period that might not have been enough for the occurrence of nutritional disorders resulting from VL. The history of fever was present in most cases, but three patients did not complain of fever or did not have fever during the treatment. The absence of hepatomegaly and anemia occurred in one case each.
It is important to mention that one patient presented with the classical symptoms of VL, having the parasitological diagnosis obtained by liver biopsy alone, and showing spontaneous remission of VL while waiting for exam results. Such cases should draw the attention of pediatricians who work in nonendemic areas to the fact that the disease may subside without treatment or that there may be cases without all the classic signs and symptoms of VL.
The use of classic methods of investigation, such as myelogram and bone marrow culture, was enough to properly diagnose VL in most cases. We opted for more invasive exams in dubious cases or in those cases in which epidemiology, clinical status and nonspecific exams did not allow for the diagnosis. 20 There have been few reports on the mechanisms involved in hypergammaglobulinemia and in the different immunoglobulin classes of VL; however, there is a direct relationship between the length of the stationary phase and the level of serum gammaglobulinemia. 21 The maintenance of hypergammaglobulinemia at the end of treatment among our patients may be related to the initial level of serum gammaglobulin and the persistence of antigen stimulation for months after treatment. The rapid recovery of albumin levels observed at the end of treatment may result from adequate nutrition during hospital stay or from the reduced catabolism of these patients.
The reports on the different IgG subclasses of active VL showed clear elevated IgG1 levels, but are controversial in terms of other IgG subclasses. El Amin et al. only found significant differences between controls and VL patients for IgG1. 22 Zwingenberger et al. obtained lower levels for IgG2 and IgG4 than those observed in the controls, and no significant difference in terms of IgG3 when these levels were compared with normal controls in the same region. 23 The mean values either for controls or VL patients in two previous reports did not take into consideration their age, which is very inadequate. The comparison of normal values obtained for immunoglobulin classes and IgG subclasses in different age groups has to be pondered, since their levels reach adult values in different periods. In our study, there was a clear predominance of IgG1 before and after treatment; however, only two patients showed reduced levels of IgG2 and other two patients had low levels of IgG3, considering the levels for each age group involved.
Radial immunodiffusion was considered adequate in this study due to the high serum levels of immunoglobulin found in VL. More sensitive and sophisticated techniques were not necessary.
Several factors were involved in the high incidence of bacterial and viral infection processes during the acute phase of VL, including malnutrition, anemia, leukopenia, possible alterations in the function of neutrophils (reduction of chemotaxis or of its bactericide capacity) or in the production of antibodies against new antigens.
Several factors (either isolated or associated) might be present in our patients, especially the mean values for hemoglobin, leukocytes and neutrophils at the beginning of diagnosis. No statistically significant difference was observed in the group that developed infection, which is in agreement with the findings obtained by Andrade et al. 24 The mean time of hospital stay (29 days) may favor exposure to hospital germs, but secondary infections found in approximately 50% of our cases were caused by infectious processes that were easily treatable with antibiotics, which is in agreement with the findings obtained by Nicodemo ET 25 and reinforces the need to carefully observe the clinical deterioration and active search of infectious agents in VL patients. In the same report, Andrade et al. observed a fourfold increase in bacterial infection in patients with VL, when compared with a control group of malnourished patients, as far as length of hospital stay was concerned. In our cases, the comparison of the mean length of hospital stay with or without secondary infection did not show statistically significant difference (P=0.05).
The pentavalent antimoniate N-methyl Glucamine (Glucantime ® ) has been used in our environment since the 1950´s and is still the initial treatment of choice, with 10% of resistant cases. In these cases, amphotericin B may be used and, more recently, it may be incorporated into artificial lipid particles (liposomes), with reduction of its systemic effects and of length of hospital stay. 16, 26 In 1990, Badaró et al. reported the use of recombinant gamma-interferon combined with pentavalent antimoniate in 17 patients with LV, with or without previous antimonial treatment, with therapeutic failure in 17% of the cases. 27 New oral drugs and vaccines for VL have been developed, offering satisfactory results; however, while these breakthroughs are not available yet, we should be careful with the diagnosis of VL and use common, highly efficient forms of diagnosis and treatment to control this endemics. 28, 29 The present study is important as a warning to pediatricians that work in low-incidence areas of VL. Because of the constant population migration that takes place in our country, VL should always be included in the differential diagnosis of patients with characteristic epidemiological, clinical and laboratory findings or even in oligosymptomatic patients, especially if they have fever and visceromegaly. Myelogram and bone marrow culture are still the diagnostic methods of choice. Antimoniate therapy is still the first recommended treatment for patients with VL in our country.
